Takeda Pharmaceuticals U.S.A., Inc. is a U.S. subsidiary of the global pharmaceutical company Takeda Pharmaceutical Company Limited. It focuses on the research, development, marketing, and commercialization of prescription medicines in the United States.
Also known as Takeda Pharmaceuticals America, Inc..
None yet. When a new project in the record names Takeda Pharmaceuticals U.S.A. as owner, partner or investor, it shows here.
Jury awarded USD 884,943,990 in single damages in AMITIZA antitrust trial; wholesaler/retailer sums subject to trebling. Will appeal, assess provision and revise FY2025 filings; minimal FY2026 impact.
